Filter
470
Text search:
Pharmaceutical
Prices
Featured
Recommendations
36
New Publications
135
Language
Document type
No document type
239
Studies & Reports
124
Guidelines
48
Strategic & Response Plan
24
Manuals
16
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
1
Countries / Regions
India
21
Global
18
Kenya
16
Uganda
14
Sierra Leone
9
Ghana
9
Ukraine
9
Liberia
8
Nigeria
8
Zambia
8
Tanzania
8
Ethiopia
7
Philippines
7
Syria
7
South Africa
7
Malawi
7
Zimbabwe
6
Nepal
6
Indonesia
6
Congo, Democratic Republic of
5
Bangladesh
5
Western and Central Europe
5
Senegal
4
Cameroon
4
Rwanda
4
Botswana
4
Myanmar / Burma
4
Venezuela
4
Haiti
3
Mozambique
3
Lesotho
3
Latin America and the Carribbean
3
Eastern Europe
3
Pakistan
2
Germany
2
Papua New Guinea
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Africa
2
Albania
2
Burkina Faso
1
Mali
1
Niger
1
South Sudan
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
China
1
Sudan
1
Central African Republic
1
North Macedonia
1
Libya
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Mongolia
1
Southern Africa
1
Laos
1
Bulgaria
1
Lithuania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
198
Clinical Guidelines
35
Public Health
18
Pharmacy & Technologies
12
Women & Child Health
7
Key Resources
7
Capacity Building
2
Toolboxes
Pharmacy
57
AMR
42
COVID-19
40
HIV
39
Mental Health
30
TB
15
Global Health Education
12
Health Financing Toolbox
11
Conflict
10
Planetary Health
8
NTDs
7
NCDs
7
Caregiver
5
Ebola
4
Rapid Response
4
Disability
3
Refugee
3
Polio
2
Cholera
1
Natural Hazards
1
Health Financing
1
Zambia National Formulary 04
recommended
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.
The report showed that while only 23 countries have implemented ce
...
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
Policy Brief
Accessed: 20.11.2019
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work
...
Technical Update
HIV Treatment
July 2017
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta
...
16-24 February 2020
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a
...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of
...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate
...
PERC produces regional and member state situation analyses, updated regularly.
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptio
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
